Hims is a direct-to-consumer pharmaceutical company selling men’s and women’s health products through virtual care on its app and website. We analyzed the company's funding activity, business model, customer acquisition strategy, market size, and competitors.
Hims is a direct-to-consumer company selling prescription and over-the-counter health products for men and women. The company differs from traditional pharmaceutical companies, serving as a platform connecting customers with prescribing physicians.
Leveraging its platform status, Hims is able to market prescription drugs for off-label uses. Examples include marketing propranolol, a beta-blocker approved to treat cardiovascular conditions, for performance anxiety, and the antidepressant Zoloft for premature ejaculation.
We analyze Hims’: